Trial · NCT03732807
Adverse event totals21
The totals the trial posted for each group.
1 to 20 of 21
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 0 | 131 |
| Total, all-cause mortality | Ritlecitinib (PF-06651600) 200 mg Then 30 mg | 0 | 129 |
| Total, all-cause mortality | Ritlecitinib (PF-06651600) 50 mg | 0 | 130 |
| Total, all-cause mortality | Ritlecitinib (PF-06651600) 30 mg | 0 | 132 |
| Total, all-cause mortality | Ritlecitinib (PF-06651600) 10 mg | 0 | 62 |
| Total, all-cause mortality | Placebo, Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 0 | 65 |
| Total, all-cause mortality | Placebo, Ritlecitinib (PF-06651600) 50 mg | 0 | 66 |
| Total, other adverse events | Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 84 | 131 |
| Total, other adverse events | Ritlecitinib (PF-06651600) 200 mg Then 30 mg | 76 | 129 |
| Total, other adverse events | Ritlecitinib (PF-06651600) 50 mg | 81 | 130 |
| Total, other adverse events | Ritlecitinib (PF-06651600) 30 mg | 77 | 132 |
| Total, other adverse events | Ritlecitinib (PF-06651600) 10 mg | 32 | 62 |
| Total, other adverse events | Placebo, Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 39 | 65 |
| Total, other adverse events | Placebo, Ritlecitinib (PF-06651600) 50 mg | 39 | 66 |
| Total, serious adverse events | Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 4 | 131 |
| Total, serious adverse events | Ritlecitinib (PF-06651600) 200 mg Then 30 mg | 2 | 129 |
| Total, serious adverse events | Ritlecitinib (PF-06651600) 50 mg | 2 | 130 |
| Total, serious adverse events | Ritlecitinib (PF-06651600) 30 mg | 1 | 132 |
| Total, serious adverse events | Ritlecitinib (PF-06651600) 10 mg | 2 | 62 |
| Total, serious adverse events | Placebo, Ritlecitinib (PF-06651600) 200 mg Then 50 mg | 0 | 65 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03732807/event-totals